Advertisement pre-approval
Advertising, publicizing or promoting medical products by visual, written, audio or social-media means requires EDE approval. Article 44(2) prohibits public advertising of the controlled, semi-controlled, hazardous or toxic products/substances it specifies; Article 44(3) allows EDE to prohibit or restrict advertising of other medical products.
- Requires a valid marketing authorization and a licensed pharmaceutical or healthcare establishment as applicant
- Material must be truthful, non-misleading, evidence-based and must clearly disclose risks or side effects
- Controlled/semi-controlled products, hazardous or toxic substances and chemical precursors may not be advertised
Effective from 2025-01-02
Official English expression independently compared in full with the UAE legislation portal; Arabic original prevails. R217 review, 18 September 2026.

